分配 COVID-19 疫苗：平衡国家和国际责任。
Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.
机构信息
University of Bergen, Norway.
Weill Cornell Medical College.
出版信息
Milbank Q. 2021 Jun;99(2):450-466. doi: 10.1111/1468-0009.12494. Epub 2020 Dec 9.
Abstract
Policy Points In this paper we propose a middle-ground policy for the distribution of an effective COVID-19 vaccine, between a cosmopolitan approach that rejects entirely nation-state priority and unbridled vaccine nationalism that disregards obligations to promote an equitable global allocation of an effective vaccine over time. Features of the COVAX partnership, a collaboration among the Global Alliance for Vaccines and Immunizations (GAVI), the Coalition for Epidemic Preparedness Innovations (CEPI), and the World Health Organization (WHO) to develop and distribute COVID-19 vaccines make it an appropriate framework for a middle-ground policy.
摘要
在本文中，我们提出了一种有效的 COVID-19 疫苗分配的中间立场政策，该政策介于完全拒绝国家优先的世界主义方法和不顾向全球分配有效疫苗的平等义务的无限制疫苗民族主义之间。COVAX 伙伴关系的特点——全球疫苗免疫联盟（GAVI）、流行病防范创新联盟（CEPI）和世界卫生组织（WHO）之间的合作，旨在开发和分发 COVID-19 疫苗，使其成为中间立场政策的适当框架。
相似文献
1
Allocating a COVID-19 Vaccine: Balancing National and International Responsibilities.分配 COVID-19 疫苗：平衡国家和国际责任。
Milbank Q. 2021 Jun;99(2):450-466. doi: 10.1111/1468-0009.12494. Epub 2020 Dec 9.
2
International Collaboration to Ensure Equitable Access to Vaccines for COVID-19: The ACT-Accelerator and the COVAX Facility.国际合作确保公平获取 COVID-19 疫苗：ACT-Accelerator 和 COVAX 设施。
Milbank Q. 2021 Jun;99(2):426-449. doi: 10.1111/1468-0009.12503. Epub 2021 Mar 2.
3
A beautiful idea: how COVAX has fallen short.一个美好的设想：新冠疫苗全球获取机制（COVAX）为何未达预期。
Lancet. 2021 Jun 19;397(10292):2322-2325. doi: 10.1016/S0140-6736(21)01367-2.
4
COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.COVID-19 疫苗和治疗的民族主义：对低收入国家和实现可持续发展目标的挑战。
Glob Public Health. 2021 Mar;16(3):319-339. doi: 10.1080/17441692.2020.1860249. Epub 2020 Dec 15.
5
Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access.新冠疫苗全球获取机制（Covax）必须超越新冠疫苗的按比例分配，以确保公平和平等的获取。
BMJ. 2021 Jan 5;372:m4853. doi: 10.1136/bmj.m4853.
6
Risky business: COVAX and the financialization of global vaccine equity.高风险的生意：COVAX 与全球疫苗公平的金融化。
Global Health. 2021 Sep 20;17(1):112. doi: 10.1186/s12992-021-00763-8.
7
Why a pioneering plan to distribute COVID vaccines equitably must succeed.为什么一项公平分发新冠疫苗的开创性计划必须成功。
Nature. 2021 Jan;589(7841):170. doi: 10.1038/d41586-021-00044-9.
8
A patent waiver on COVID vaccines is right and fair.新冠疫苗专利豁免是正确且公平的。
Nature. 2021 May;593(7860):478. doi: 10.1038/d41586-021-01242-1.
9
[Dilemma, causes and countermeasures of global health governance: taking COVID-19 Vaccines Global Access Facility as an example].[全球卫生治理的困境、成因与对策：以新冠疫苗全球获取机制为例]
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Apr 10;43(4):483-487. doi: 10.3760/cma.j.cn112338-20211216-00987.
10
Canada is no global health leader on COVID-19 vaccine equity.在新冠疫苗公平性方面，加拿大并非全球健康领域的领导者。
Lancet. 2021 May 15;397(10287):1803. doi: 10.1016/S0140-6736(21)00888-6.
引用本文的文献
1
A critical analysis of COVAX alliance and corresponding global health governance and policy issues: a scoping review.对 COVAX 联盟及相应的全球卫生治理和政策问题的批判性分析：范围综述。
BMJ Glob Health. 2023 Oct;8(10). doi: 10.1136/bmjgh-2023-012168.
2
Voluntariness or legal obligation? An ethical analysis of two instruments for fairer global access to COVID-19 vaccines.自愿还是法律义务？对实现更公平获取 COVID-19 疫苗的两种工具的伦理分析。
Front Public Health. 2023 Jan 26;11:995683. doi: 10.3389/fpubh.2023.995683. eCollection 2023.
3
Vaccine equity in COVID-19: a meta-narrative review.新冠疫苗公平性：元叙述性综述。
BMJ Glob Health. 2022 Dec;7(12). doi: 10.1136/bmjgh-2022-009876.
4
COVID-19 Vaccination Policies: Ethical Issues and Responsibility.COVID-19疫苗接种政策：伦理问题与责任
Vaccines (Basel). 2022 Sep 23;10(10):1602. doi: 10.3390/vaccines10101602.
5
Community Health Resources, Globalization, Trust in Science, and Voting as Predictors of COVID-19 Vaccination Rates: A Global Study with Implications for Vaccine Adherence.社区卫生资源、全球化、对科学的信任以及投票作为新冠疫苗接种率的预测因素：一项对疫苗接种依从性有影响的全球研究。
Vaccines (Basel). 2022 Aug 18;10(8):1343. doi: 10.3390/vaccines10081343.
6
COVID-19 in Low- and Middle-Income Countries (LMICs): A Narrative Review from Prevention to Vaccination Strategy.低收入和中等收入国家的2019冠状病毒病：从预防到疫苗接种策略的叙述性综述
Vaccines (Basel). 2021 Dec 14;9(12):1477. doi: 10.3390/vaccines9121477.
7
On the Ethics of Vaccine Nationalism: The Case for the Fair Priority for Residents Framework.论疫苗民族主义的伦理：居民公平优先框架之实例
Ethics Int Aff. 2021 Winter;35(4):543-562. doi: 10.1017/s0892679421000514. Epub 2021 Oct 29.
8
Booster or additional vaccination doses in patients vaccinated against COVID-19.针对已接种 COVID-19 疫苗的患者的加强针或额外疫苗接种剂量。
Rev Esp Quimioter. 2022 Apr;35(2):105-114. doi: 10.37201/req/149.2021. Epub 2021 Nov 15.
9
COVID-19 Pandemic and Equal Access to Vaccines.新冠疫情与疫苗的平等可及性
Vaccines (Basel). 2021 May 21;9(6):538. doi: 10.3390/vaccines9060538.
本文引用的文献
1
An ethical framework for global vaccine allocation.全球疫苗分配的伦理框架。
Science. 2020 Sep 11;369(6509):1309-1312. doi: 10.1126/science.abe2803. Epub 2020 Sep 3.
Zotero 插件